Colorectal cancer prevention

A. Ismail, E. Gerner, Michael P Lance

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Adenocarcinomas of the colon and rectum (colorectal cancer, CRC) are malignant epithelial neoplasms. A polyp is a localized lesion that projects above the surrounding mucosa. Adenomatous polyps (adenomas) are benign neoplasms that arise from colorectal glandular epithelium. In the United States (US), colorectal adenoma (CRA) prevalence is approximately 25% by age 50 and rises to around 50% by age 70. The histological hallmarks of a CRA are altered glandular architecture and dysplasia of the epithelium. The great majority of CRCs develop from CRAs in a process called the adenoma-carcinoma sequence. This process may take from years to decades for the earliest CRA to progress to CRC (Leslie et al. 2002). A CRA progresses to become a CRC when the dysplastic cells invade through the muscularis mucosa. While most CRCs develop from CRAs, fewer than 10% of CRAs ever progress to CRC. Hyperplastic colorectal polyps are histologically distinct from CRAs, occur most frequently in the rectum and sigmoid colon, are not neoplastic and do not progress to CRC. Besides CRAs, the inflammatory bowel diseases, ulcerative colitis (UC) and Crohn's disease of the colon (Crohn's colitis), predispose to CRC. CRCs evolve through distinct genetic pathways involving genetic instability, which is the driving force for tumor development (Lengauer et al. 1998). Three genetic instability pathways have been identified in CRC. They are called chromosomal instability (Rajagopalan et al. 2003), microsatellite instability (MSI), and the CpG island methylator phenotype (CIMP). Chromosomal instability is the tumorigenic mechanism in FAP and in approximately 85% of sporadic CRCs that develop as a result of losses of both APC alleles and other tumor suppressor genes (Vogelstein et al. 1988). HNPCC and the remaining 15% of sporadic CRCs develop because of MSI that results from inactivation of the DNA MMR system (Ionov et al. 1993). Clusters of cytosine-guanosine pairs, termed CpG islands, in the promoter regions of many genes are prone to age-related methylation. Such hypermethylation can lead to gene silencing. In a proportion of CRCs, functional loss of certain tumor suppressor genes is caused by CpG island methylation and silencing rather than mutations (Toyota et al. 1999).

Original languageEnglish (US)
Title of host publicationFundamentals of Cancer Prevention
PublisherSpringer Berlin Heidelberg
Pages291-312
Number of pages22
ISBN (Print)9783540242123
DOIs
StatePublished - 2005

Fingerprint

Colorectal Neoplasms
Adenoma
CpG Islands
Chromosomal Instability
Microsatellite Instability
Polyps
Tumor Suppressor Genes
Methylation
Colon
Mucous Membrane
Epithelium
Carcinoma
Adenomatous Polyps
Guanosine
Cytosine
Gene Silencing
Sigmoid Colon
Colitis
Rectal Neoplasms
Ulcerative Colitis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ismail, A., Gerner, E., & Lance, M. P. (2005). Colorectal cancer prevention. In Fundamentals of Cancer Prevention (pp. 291-312). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-68986-7_12

Colorectal cancer prevention. / Ismail, A.; Gerner, E.; Lance, Michael P.

Fundamentals of Cancer Prevention. Springer Berlin Heidelberg, 2005. p. 291-312.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ismail, A, Gerner, E & Lance, MP 2005, Colorectal cancer prevention. in Fundamentals of Cancer Prevention. Springer Berlin Heidelberg, pp. 291-312. https://doi.org/10.1007/978-3-540-68986-7_12
Ismail A, Gerner E, Lance MP. Colorectal cancer prevention. In Fundamentals of Cancer Prevention. Springer Berlin Heidelberg. 2005. p. 291-312 https://doi.org/10.1007/978-3-540-68986-7_12
Ismail, A. ; Gerner, E. ; Lance, Michael P. / Colorectal cancer prevention. Fundamentals of Cancer Prevention. Springer Berlin Heidelberg, 2005. pp. 291-312
@inbook{b9c4ac5f982d422c97915939dd723388,
title = "Colorectal cancer prevention",
abstract = "Adenocarcinomas of the colon and rectum (colorectal cancer, CRC) are malignant epithelial neoplasms. A polyp is a localized lesion that projects above the surrounding mucosa. Adenomatous polyps (adenomas) are benign neoplasms that arise from colorectal glandular epithelium. In the United States (US), colorectal adenoma (CRA) prevalence is approximately 25{\%} by age 50 and rises to around 50{\%} by age 70. The histological hallmarks of a CRA are altered glandular architecture and dysplasia of the epithelium. The great majority of CRCs develop from CRAs in a process called the adenoma-carcinoma sequence. This process may take from years to decades for the earliest CRA to progress to CRC (Leslie et al. 2002). A CRA progresses to become a CRC when the dysplastic cells invade through the muscularis mucosa. While most CRCs develop from CRAs, fewer than 10{\%} of CRAs ever progress to CRC. Hyperplastic colorectal polyps are histologically distinct from CRAs, occur most frequently in the rectum and sigmoid colon, are not neoplastic and do not progress to CRC. Besides CRAs, the inflammatory bowel diseases, ulcerative colitis (UC) and Crohn's disease of the colon (Crohn's colitis), predispose to CRC. CRCs evolve through distinct genetic pathways involving genetic instability, which is the driving force for tumor development (Lengauer et al. 1998). Three genetic instability pathways have been identified in CRC. They are called chromosomal instability (Rajagopalan et al. 2003), microsatellite instability (MSI), and the CpG island methylator phenotype (CIMP). Chromosomal instability is the tumorigenic mechanism in FAP and in approximately 85{\%} of sporadic CRCs that develop as a result of losses of both APC alleles and other tumor suppressor genes (Vogelstein et al. 1988). HNPCC and the remaining 15{\%} of sporadic CRCs develop because of MSI that results from inactivation of the DNA MMR system (Ionov et al. 1993). Clusters of cytosine-guanosine pairs, termed CpG islands, in the promoter regions of many genes are prone to age-related methylation. Such hypermethylation can lead to gene silencing. In a proportion of CRCs, functional loss of certain tumor suppressor genes is caused by CpG island methylation and silencing rather than mutations (Toyota et al. 1999).",
author = "A. Ismail and E. Gerner and Lance, {Michael P}",
year = "2005",
doi = "10.1007/978-3-540-68986-7_12",
language = "English (US)",
isbn = "9783540242123",
pages = "291--312",
booktitle = "Fundamentals of Cancer Prevention",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Colorectal cancer prevention

AU - Ismail, A.

AU - Gerner, E.

AU - Lance, Michael P

PY - 2005

Y1 - 2005

N2 - Adenocarcinomas of the colon and rectum (colorectal cancer, CRC) are malignant epithelial neoplasms. A polyp is a localized lesion that projects above the surrounding mucosa. Adenomatous polyps (adenomas) are benign neoplasms that arise from colorectal glandular epithelium. In the United States (US), colorectal adenoma (CRA) prevalence is approximately 25% by age 50 and rises to around 50% by age 70. The histological hallmarks of a CRA are altered glandular architecture and dysplasia of the epithelium. The great majority of CRCs develop from CRAs in a process called the adenoma-carcinoma sequence. This process may take from years to decades for the earliest CRA to progress to CRC (Leslie et al. 2002). A CRA progresses to become a CRC when the dysplastic cells invade through the muscularis mucosa. While most CRCs develop from CRAs, fewer than 10% of CRAs ever progress to CRC. Hyperplastic colorectal polyps are histologically distinct from CRAs, occur most frequently in the rectum and sigmoid colon, are not neoplastic and do not progress to CRC. Besides CRAs, the inflammatory bowel diseases, ulcerative colitis (UC) and Crohn's disease of the colon (Crohn's colitis), predispose to CRC. CRCs evolve through distinct genetic pathways involving genetic instability, which is the driving force for tumor development (Lengauer et al. 1998). Three genetic instability pathways have been identified in CRC. They are called chromosomal instability (Rajagopalan et al. 2003), microsatellite instability (MSI), and the CpG island methylator phenotype (CIMP). Chromosomal instability is the tumorigenic mechanism in FAP and in approximately 85% of sporadic CRCs that develop as a result of losses of both APC alleles and other tumor suppressor genes (Vogelstein et al. 1988). HNPCC and the remaining 15% of sporadic CRCs develop because of MSI that results from inactivation of the DNA MMR system (Ionov et al. 1993). Clusters of cytosine-guanosine pairs, termed CpG islands, in the promoter regions of many genes are prone to age-related methylation. Such hypermethylation can lead to gene silencing. In a proportion of CRCs, functional loss of certain tumor suppressor genes is caused by CpG island methylation and silencing rather than mutations (Toyota et al. 1999).

AB - Adenocarcinomas of the colon and rectum (colorectal cancer, CRC) are malignant epithelial neoplasms. A polyp is a localized lesion that projects above the surrounding mucosa. Adenomatous polyps (adenomas) are benign neoplasms that arise from colorectal glandular epithelium. In the United States (US), colorectal adenoma (CRA) prevalence is approximately 25% by age 50 and rises to around 50% by age 70. The histological hallmarks of a CRA are altered glandular architecture and dysplasia of the epithelium. The great majority of CRCs develop from CRAs in a process called the adenoma-carcinoma sequence. This process may take from years to decades for the earliest CRA to progress to CRC (Leslie et al. 2002). A CRA progresses to become a CRC when the dysplastic cells invade through the muscularis mucosa. While most CRCs develop from CRAs, fewer than 10% of CRAs ever progress to CRC. Hyperplastic colorectal polyps are histologically distinct from CRAs, occur most frequently in the rectum and sigmoid colon, are not neoplastic and do not progress to CRC. Besides CRAs, the inflammatory bowel diseases, ulcerative colitis (UC) and Crohn's disease of the colon (Crohn's colitis), predispose to CRC. CRCs evolve through distinct genetic pathways involving genetic instability, which is the driving force for tumor development (Lengauer et al. 1998). Three genetic instability pathways have been identified in CRC. They are called chromosomal instability (Rajagopalan et al. 2003), microsatellite instability (MSI), and the CpG island methylator phenotype (CIMP). Chromosomal instability is the tumorigenic mechanism in FAP and in approximately 85% of sporadic CRCs that develop as a result of losses of both APC alleles and other tumor suppressor genes (Vogelstein et al. 1988). HNPCC and the remaining 15% of sporadic CRCs develop because of MSI that results from inactivation of the DNA MMR system (Ionov et al. 1993). Clusters of cytosine-guanosine pairs, termed CpG islands, in the promoter regions of many genes are prone to age-related methylation. Such hypermethylation can lead to gene silencing. In a proportion of CRCs, functional loss of certain tumor suppressor genes is caused by CpG island methylation and silencing rather than mutations (Toyota et al. 1999).

UR - http://www.scopus.com/inward/record.url?scp=84889972733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889972733&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-68986-7_12

DO - 10.1007/978-3-540-68986-7_12

M3 - Chapter

AN - SCOPUS:84889972733

SN - 9783540242123

SP - 291

EP - 312

BT - Fundamentals of Cancer Prevention

PB - Springer Berlin Heidelberg

ER -